CYYNFCynata Therapeutics Limited
Oct 15, 2026 — Liquidity Extension / Capital Raise
Chart by TradingViewThe schedule
- Thu15Oct
Anticipated dilutive equity financing or structured debt issuance required to maintain operations and fund clinical milestones.
- Fri20Nov
Expected trial progression updates on Cynata's iPSC-derived mesenchymal stem cell (MSC) pipeline across active indications (e.g., GVHD or osteoarthritis).
- Fri26Feb
First-half 2027 results detailing the updated capital structure and ongoing R&D expenditures.
Past
- Mon31Aug
Release of the full-year results for the period ending June 30, 2026, focusing heavily on runway visibility and the Cymerus platform updates.